Open AccessNifuroxazide Erythema Pigmented Fixed: A Side Effect to Be Aware Off
Author(s) -
Ryme Dassouli,
Zakia Douhi,
Imane Kacimi,
Kenza Tahiri,
Hanane BayBay,
Sara Elloudi,
Fatima Zahra Mernissi
Publication year - 2022
Language(s) - English
DOI - 10.46889/jdr.2022.3107
Subject(s) - erythema , dermatology , hyperpigmentation , medicine , rash
Erythema Pigmentum Fixata (EPF) is a delayed-type toxidermia. It manifests itself within 48h after the re-introduction of a drug by the appearance of a recurrent rash, leaving a residual hyperpigmentation [1]. We report a first case of erythema pigmentosa fixed to Nifuroxazide.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom